{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This randomized controlled trial aimed to compare the postoperative analgesic efficacy of liposomal bupivacaine versus bupivacaine hydrochloride in patients receiving QLB-LSAL after laparoscopic nephrectomy."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomly assigned to two groups in a 1:1 ratio."
      },
      "Participants": {
        "score": 2,
        "evidence": "A total of 116 patients were scheduled to undergo elective laparoscopic nephrectomy under general anesthesia."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The liposomal bupivacaine group (n = 53) received a mixture of 10 mL of liposomal bupivacaine (133mg) and 10 mL of normal saline, totaling 20 mL, while the bupivacaine hydrochloride group (n = 53) received 20 mL of 0.375% bupivacaine hydrochloride."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomized controlled trial aimed to compare the postoperative analgesic efficacy of liposomal bupivacaine versus bupivacaine hydrochloride in patients receiving QLB-LSAL after laparoscopic nephrectomy."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was total morphine equivalent consumption within the first 48 hours postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients were randomly assigned to two groups in a 1:1 ratio."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 116 patients were scheduled to undergo elective laparoscopic nephrectomy under general anesthesia."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The liposomal bupivacaine group (n = 53) received a mixture of 10 mL of liposomal bupivacaine (133mg) and 10 mL of normal saline, totaling 20 mL, while the bupivacaine hydrochloride group (n = 53) received 20 mL of 0.375% bupivacaine hydrochloride."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The total consumption of morphine equivalents within 48 hours postoperatively was significantly lower in the liposomal bupivacaine group than in the bupivacaine hydrochloride group (mean \u00b1 SD: 31.8 \u00b1 2.3 vs 20.7 \u00b1 2.8, 95% Confidence Intervals: 10.1 to 12.1, P < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "no significant difference in the incidence of adverse events (P > 0.05) was observed between the two groups."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 16,
    "max_score": 25
  },
  "model": "gpt-4o"
}